Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 2
1977 1
1978 1
1979 2
1980 1
1982 3
1983 2
1984 2
1989 4
1990 4
1991 2
1992 1
1993 3
1994 4
1995 2
1996 3
1997 1
1998 1
1999 4
2000 1
2001 4
2002 2
2003 5
2004 4
2005 4
2006 3
2007 6
2008 3
2009 1
2010 2
2011 1
2012 1
2013 2
2014 6
2015 3
2016 8
2017 5
2018 4
2019 7
2020 3
2021 4
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Childhood Hodgkin Lymphoma"
Page 1
Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities.
Burkhardt B, Hermiston ML. Burkhardt B, et al. Br J Haematol. 2019 Jun;185(6):1158-1170. doi: 10.1111/bjh.15793. Epub 2019 Feb 27. Br J Haematol. 2019. PMID: 30809797 Free article. Review.
Lymphoblastic lymphoma (LBL) is the second most common type of Non-Hodgkin Lymphoma (NHL) in childhood and adolescence, accounting for 25-35% of all cases. ...An additional challenge is the dismal prognosis of patients with refractory or relapsed di …
Lymphoblastic lymphoma (LBL) is the second most common type of Non-Hodgkin Lymphoma (NHL) in childhood and adole …
Chlorambucil-induced seizures.
Salloum E, Khan KK, Cooper DL. Salloum E, et al. Cancer. 1997 Mar 1;79(5):1009-13. doi: 10.1002/(sici)1097-0142(19970301)79:5<1009::aid-cncr18>3.0.co;2-5. Cancer. 1997. PMID: 9041164 Review.
Underlying diseases included nephrotic syndrome (n = 12 cases), solid tumors (n - 10 cases), non-Hodgkin's lymphoma (n = 3 cases), and chronic lymphocytic leukemia (n = 1 case). ...Nine of 14 adults received high dose chlorambucil in Phase I-II studies or as part of …
Underlying diseases included nephrotic syndrome (n = 12 cases), solid tumors (n - 10 cases), non-Hodgkin's lymphoma (n = 3 cas …
Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.
Miles RR, Shah RK, Frazer JK. Miles RR, et al. Br J Haematol. 2016 May;173(4):582-96. doi: 10.1111/bjh.14011. Epub 2016 Mar 11. Br J Haematol. 2016. PMID: 26969846 Free PMC article. Review.
Molecular genetic abnormalities are ubiquitous in non-Hodgkin lymphoma (NHL), but genetic changes are not yet used to define specific lymphoma subtypes. Certain recurrent molecular genetic abnormalities in NHL underlie molecular pathogenesis and/or are …
Molecular genetic abnormalities are ubiquitous in non-Hodgkin lymphoma (NHL), but genetic changes are not yet used to define s …
Hydroa vacciniforme-like lymphoproliferative disorder in Korea.
Han B, Hur K, Ohn J, Kim TM, Jeon YK, Kim YC, Mun JH. Han B, et al. Sci Rep. 2020 Nov 9;10(1):19294. doi: 10.1038/s41598-020-76345-2. Sci Rep. 2020. PMID: 33168864 Free PMC article.
Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein-Barr virus (EBV)-associated lymphoproliferative disease. The disease course of HVLPD varies from an indolent course to progression to aggressive lymphoma. ...HVLPD has various cli …
Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein-Barr virus (EBV)-associated lymphoproliferative disease …
Management of pediatric non-Hodgkin's lymphoma.
Blay JY, Louis D, Bouffet E, Thiesse P, Biron P, Favrot MC, Brunat-Mentigny M, Philip T. Blay JY, et al. Blood Rev. 1991 Jun;5(2):90-7. doi: 10.1016/0268-960x(91)90040-j. Blood Rev. 1991. PMID: 1912759 Review.
Over the past 15 years, significant progress has been made in the understanding of the molecular mechanism involved in malignant transformation of lymphocytes as well as in the management and treatment of non-Hodgkin's lymphoma (NHL) in childhood. Cyto-histol …
Over the past 15 years, significant progress has been made in the understanding of the molecular mechanism involved in malignant transformat …
Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: Report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study).
Rahiman EA, Bakhshi S, Deepam Pushpam, Ramamoorthy J, Das A, Ghara N, Kalra M, Kapoor G, Meena JP, Siddaigarhi S, Thulkar S, Sharma MC, Srinivasan R, Trehan A. Rahiman EA, et al. Pediatr Hematol Oncol. 2022 Aug;39(5):391-405. doi: 10.1080/08880018.2021.2002485. Epub 2022 Jan 3. Pediatr Hematol Oncol. 2022. PMID: 34978257
The literature on B-non-Hodgkin lymphoma (NHL) in India is restricted to individual hospital data. ...Hypoalbuminemia was noted in 82/170 (48.2%). Histological subtypes: Burkitt lymphoma (BL): 69.6%, Burkitt-like: 10.4%, and diffuse large B cell lymphoma …
The literature on B-non-Hodgkin lymphoma (NHL) in India is restricted to individual hospital data. ...Hypoalbuminemia was note …
Clinicopathologic features and therapy outcome in childhood Hodgkin's lymphoma: a report from tertiary care center in Saudi Arabia.
Alkhayat N, Alshahrani M, Elyamany G, Sedick Q, Ibrahim W, Hamzi H, Binhassan A, Othman M, Alshieban S, Aljabry MS, Asiri S, Alzouman M, Alsuhaibani O, Alabbas F, Alsharif O, Elborai Y. Alkhayat N, et al. J Egypt Natl Canc Inst. 2021 Aug 16;33(1):21. doi: 10.1186/s43046-021-00078-0. J Egypt Natl Canc Inst. 2021. PMID: 34396456
BACKGROUND: Hodgkin lymphoma (HL) is lymphoid neoplasm usually affecting lymphatic system; it accounts 3.6% of cancers in Saudi Arabia. ...Also, they did not experience chronic pulmonary or cardiotoxicity. Classic Hodgkin's lymphoma: nodular sclerosis …
BACKGROUND: Hodgkin lymphoma (HL) is lymphoid neoplasm usually affecting lymphatic system; it accounts 3.6% of cancers in Saud …
Diagnosis and treatment of childhood non-hodgkin lymphoma.
Reiter A. Reiter A. Hematology Am Soc Hematol Educ Program. 2007:285-96. doi: 10.1182/asheducation-2007.1.285. Hematology Am Soc Hematol Educ Program. 2007. PMID: 18024642 Review.
Major advances have been made in the treatment of childhood non-Hodgkin lymphoma (NHL). The recognition that different NHL subtypes require different treatment strategies was fundamental to developing successful therapy regimens. Currently established therapy …
Major advances have been made in the treatment of childhood non-Hodgkin lymphoma (NHL). The recognition that different …
Childhood non-Hodgkin's lymphoma involving the testis: clinical features and treatment outcome.
Kellie SJ, Pui CH, Murphy SB. Kellie SJ, et al. J Clin Oncol. 1989 Aug;7(8):1066-70. doi: 10.1200/JCO.1989.7.8.1066. J Clin Oncol. 1989. PMID: 2666589 Review.
Among 131 boys with advanced (stage III or IV) non-Hodgkin's lymphoma (NHL) consecutively treated at St. Jude Children's Research Hospital, testicular involvement was present at the time of diagnosis in six and as an isolated site of relapse in three. ...Overt testi …
Among 131 boys with advanced (stage III or IV) non-Hodgkin's lymphoma (NHL) consecutively treated at St. Jude Children's Resea …
Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphoma.
Waibel M, Gregory G, Shortt J, Johnstone RW. Waibel M, et al. Curr Opin Hematol. 2014 Jul;21(4):297-308. doi: 10.1097/MOH.0000000000000045. Curr Opin Hematol. 2014. PMID: 24811162 Review.
PURPOSE OF REVIEW: The identification of oncogenic 'driver' mutations and activated survival pathways in selected aggressive B-cell malignancies directs the development of novel adjunctive therapies using targeted small molecule inhibitors. With a focus on diffuse large B-cell …
PURPOSE OF REVIEW: The identification of oncogenic 'driver' mutations and activated survival pathways in selected aggressive B-cell malignan …
118 results